JODY KITTLE: Open Payments
NPI 1710642558 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,805 in 73 payments from 15 companies in 2025. Trend: 2023 $904 · 2024 $2,162 · 2025 $1,805
Food & beverage: $1,805
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 17 | $505 |
| ABBVIE INC. | 17 | $333 |
| E.R. Squibb & Sons, L.L.C. | 7 | $222 |
| Alkermes, Inc. | 4 | $178 |
| Corium, LLC | 6 | $126 |
| Tris Pharma Inc | 5 | $103 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $97 |
| Bausch Health US, LLC | 3 | $62 |
| Vanda Pharmaceuticals Inc. | 2 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
Products named: Auvelity, VRAYLAR, COBENFY, Azstarys, LYBALVI, Dyanavel XR, CAPLYTA, APLENZIN.
Industry payments across LA — which companies pay providers there.
